DVA Trading Analysis - 10/07/2026 10:44 AM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for DaVita (DVA) that may frame the current data environment:

• DaVita expands home dialysis partnerships with major health systems amid rising end-stage renal disease prevalence.
• CMS proposed 2027 reimbursement rate changes for ESRD facilities, creating sector-wide margin uncertainty.
• Activist shareholder pressure continues regarding capital allocation and potential share buybacks.
• Labor cost inflation in healthcare staffing remains a cited headwind in recent sector earnings calls.
• No confirmed near-term earnings date in provided data; fiscal year end listed as 2025-12-01.

Context: These broader catalysts contrast with the embedded technical weakness (RSI 32.39, price below 50-day SMA) and balanced options sentiment, suggesting fundamental stability but near-term technical pressure.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E: 14.50; Trailing EPS: $12.46; Market Cap: $11,641,905,000.00
• Shares Outstanding: 63,800,000.00; Dividend Yield: 0.00%; Beta: 1.23
• 52-Week High: $247.49; 52-Week Low: $101.00
• Institutional Ownership: 28.91%; Average Volume: 702,000.00
• Historical Volatility: 31.32%; Fiscal Year End: 2025-12-01
• PEG Ratio: null; Forward P/E: null; Price-to-Book: null
• Revenue Growth: null; Profit Margins: null; ROE: null; Debt/Equity: null; Free Cash Flow: null
• Analyst Target Mean Price: null; Recommendation Key: null

Strengths: Low trailing P/E of 14.50 vs sector averages implies relatively cheap earnings. Concerns: Missing margin, growth, and leverage metrics limit visibility. Fundamentals show value characteristics but diverge from technical weakness (price below SMA_50 of $187.25 and RSI near oversold).

Current Market Position

Current price per indicators: $180.80 (as of 2026-10-06 close). Minute bars show 2026-10-07 10:15 close at $182.38, up from 2026-10-06 09:30 open of $179.88.

Intraday momentum: Early 2026-10-06 dipped to $178.88 then recovered; 2026-10-07 session traded $181.44–$182.38 with thin volume late bars (887–3,050).

Technical Analysis

SMA alignment: Price ($180.80) > SMA_5 ($178.17) but < SMA_20 ($181.65) and < SMA_50 ($187.25): bearish stack. No golden cross; SMA_5 below SMA_20 and SMA_50 confirms downtrend.

RSI 32.39: approaching oversold, weak momentum. MACD negative with histogram -0.61: bearish continuation. Bollinger: price near lower-middle, no squeeze (width $20.00). 30-day range $173.37–$195.75: price in lower third.

True Sentiment Analysis (Delta 40-60 Options)

Per embedded options JSON: Call Dollar Vol $0.00, Put Dollar Vol $0.00, Total $0.00, Sentiment: Balanced. True sentiment options analyzed: 0 of 804 (filter 0.0%).

Conviction: No directional flow captured; neutral. Divergence: technicals bearish (RSI 32, MACD neg) but sentiment flat — no confirmation of downside acceleration.

Key Price Levels (Observational Only)